EGFR is found to be expressed aberrantly in many solid tumors like lung [69], colorectal cancers [70], head and neck squamous cancers [71], and breast cancers, where around 25–30% cases are attributed to EGFR overexpression [72,73,74]. This evidence concerns the gene EGFR and breast carcinoma.